Three recent reports have directly assessed the possible involvement of purinergic receptors in the immunopathogenesis of HIV-1 infection, raising the possibility of using these host proteins as targets for HIV-1 treatment. This evidence concerns the gene P2RY2 and HIV-1 infection.